Overview
Fresenius Nephrocare Polska is involved in providing chronic and acute kidney dialysis services and therapeutic apheresis. The company offers products and therapies specifically designed for healthcare professionals and patients dealing with chronic kidney disease. Additionally, they engage in research related to hemodiafiltration and its impact on hospitalization for end-stage kidney disease (ESKD).
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2002-01-01. Active
42 1880 0009 0000 0011 0155 9000
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 9, 2013 | Commercial Companies Code notice | |
| Jul 11, 2013 | Commercial Companies Code notice | |
| Sep 14, 2010 | Commercial Companies Code notice | |
| Sep 14, 2010 | Commercial Companies Code notice | |
| Jun 10, 2010 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-04-02 | Choroba nie czeka, Ty też nie czekaj - rozwój profilaktyki nowotworowej w kierunku wykrywania raka jelita grubego w Powiecie Łobeskim przez NZOZ INTERMED Sp. z o.o. | $482,943 | Regionalny Program Operacyjny Województwa Zachodniopomorskiego 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the sole member of the management board represents the company independently. If the management board is a multi-member management board, the company may be represented by two members of the management board jointly, or by one member of the management board jointly with one commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 271,704 | $36,696,920.58 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Jakub Jan Janiak (44)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Michał Łyskawa (44) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Marcin Mariak (50) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | |
| Nutrimedsp. z o.o. | $64,888,288.93 | nutrimed.pl | |
| Prodomumsp. z o.o. | $40,062,555.38 | prodomum.pl | |
| Centrum Diagnostyczno - Terapeutyczne Medicussp. z o.o. | $37,437,289.14 | cdtmedicus.pl | |
| Falck Medycynasp. z o.o. | $35,168,257.16 | falck.pl | |
| ARS Medicalsp. z o.o. | $30,982,068.72 | arsmedical.pila.pl | |
| Medpharma Zakład Opieki ZdrowotnejS.A. | $19,218,791.99 | medpharma.pl | |
| Aldemed Centrum Medycznesp. z o.o. | $17,163,375.93 | aldemed.pl |
Change history
| Date | Event |
|---|---|
| 2013-07-01 | Share capital change (99,071,500.00 PLN → 135,852,000.00 PLN) |
| 2012-04-27 | Share capital change (102,124,000.00 PLN → 99,071,500.00 PLN) |
| 2010-02-18 | Share capital change (98,548,000.00 PLN → 102,124,000.00 PLN) |
| 2008-10-30 | Share capital change (89,698,000.00 PLN → 98,548,000.00 PLN) |
| 2008-04-28 | Share capital change (84,211,000.00 PLN → 89,698,000.00 PLN) |
FAQ
Last updated: 2026-07-09